If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Cruzan International, Inc.

Full Name of Registrant

Todhunter International, Inc.

Former Name if Applicable

222 Lakeview Avenue, Suite 1500

Address of Principal Executive Office (Street and Number)

West Palm Beach, FL 33401

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

PART III — NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

(Attach extra Sheets if Needed)

 

The registrant has not completed the preparation of its unaudited financial statements for its Form 10-Q for the quarter ended March 31, 2005.  The registrant intends to file its Form 10-Q within the 5-calendar day extension provided by Rule 12b-25.

 

SEC 1344 (07-03)

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

PART IV — OTHER INFORMATION

 

(1)	Name and telephone number of person to contact in regard to this notification
	Ezra Shashoua		(561)		655-8977
	(Name)		(Area Code)		(Telephone Number)
(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
ý Yes						o No
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
ý Yes						o No
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

Net Sales for the three months and six months ended March 31, 2005 is expected to be $25,511,634 and $49,703,827, respectively, compared with $22,039,843 and $44,481,495, for the three months and six months ended March 31, 2004, respectively.

 

Gross Profit for the three months and six months ended March 31, 2005 is expected to be $8,855,625 and $16,930,617, respectively, compared to $8,329,364 and $15,905,993, respectively, in the same time periods in fiscal 2004.

 

Operating Income (Loss) for the three months and six months ended March 31, 2005 is expected to be $2,744 and ($228,274) respectively, compared to $1,390,126 and $2,275,548 for the three months and six months ended March 31, 2004, respectively.

 

Net Income (Loss) for the three months and six months ended March 31, 2005 is expected to be ($70,785) and $78,306, respectively, compared to $1,118,530 and $1,969,814, respectively, for the comparable periods last year.

 

The decreases in Operating Income (Loss) and Net Income (Loss) are primarily a result of increased administrative, marketing and advertising expenses in the Company's premium branded spirits business as the Company continues to place emphasis on this growing business segment.

 

 

Cruzan International, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date	May 16, 2005		By	/s/ Ezra Shashoua,
				Ezra Shashoua,
				Executive Vice President and
				Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.